Market revenue in 2023 | USD 11.4 million |
Market revenue in 2030 | USD 15.9 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 24.56% in 2023. Horizon Databook has segmented the Japan dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is anticipated to account for a significant share of Asia Pacific market, as it has one of the most developed pharmaceutical and biotechnology sectors in the region. In addition, the presence of a wellestablished healthcare system and high adoption of advanced technology for early diagnosis & treatment of infectious & chronic diseases are expected to boost the market in the country.
Furthermore, presence of DBS collection card manufacturers in the region and continuous R&D activities by them for introduction of innovative DBS collection cards have significantly supported market growth in Japan.
Moreover, growing prevalence of chronic and infectious diseases in the country is anticipated to boost demand for DBS collection cards for early diagnosis, which is anticipated to propel market growth. However, DBS is not approved for collecting samples for HIV testing in the region. Hence, this prevents the market from growing at its full potential.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan dried blood spot collection cards market , including forecasts for subscribers. This country databook contains high-level insights into Japan dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account